Clyde L Schultz

Title: Innovations by Clyde L Schultz in Ophthalmic Technology

Introduction

Clyde L Schultz is a notable inventor based in Ponte Vedra Beach, FL (US). He has made significant contributions to the field of ophthalmic technology, particularly in the development of advanced contact lenses. With a total of 2 patents, his work focuses on enhancing the safety and effectiveness of lenses used in vision correction.

Latest Patents

One of his latest patents is for a contact lens containing a leachable absorbed material. This innovative lens is made of a polymeric hydrogel material that has absorbed desferrioxamine as a leachable additive. The method for creating this composition involves soaking the polymeric material in a solution of the additive. Another significant patent is for an ophthalmic lens with an anti-toxin agent. This lens is designed for placement on the anterior surface of the eye and features an ester of a polyhydric aliphatic alcohol and a fatty acid. The ester is present in an effective amount to prevent or decrease the release of bacterial toxins when the lens is exposed to those toxins. This innovation is particularly beneficial for soft hydrogel contact lenses, as it helps to eliminate, minimize, or prevent keratitis, an infection of the cornea that can occur during extended wear.

Career Highlights

Clyde L Schultz is associated with Johnson & Johnson Vision Products Inc., where he continues to contribute to advancements in eye care technology. His work has been instrumental in developing products that enhance the safety and comfort of contact lens wearers.

Collaborations

Some of his notable coworkers include Douglas G Vanderlaan and Susan Kay Brown-Skrobot, who have collaborated with him on various projects within the company.

Conclusion

Clyde L Schultz's innovations in ophthalmic technology have significantly impacted the field of vision correction. His patents reflect a commitment to improving the safety and effectiveness of contact lenses, benefiting countless users worldwide.